4.6 Article

Effects of risperidone on psychotic symptoms and cognitive functions in 22q11.2 deletion syndrome: Results from a clinical trial

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Age-Related Improvements in Executive Functions and Focal Attention in 22q11.2 Deletion Syndrome Vary Across Domain and Task

Johanna Maeder et al.

Summary: In this study, differential impairments and trajectories in specific EF subdomains among individuals with 22q11DS were identified. Lower overall inhibition skills and slower pace of initiation skills development compared to healthy controls were observed. The necessity of extensive, multifaceted evaluations to gain a more reliable overview of patients' cognitive profile was emphasized.

JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2022)

Article Psychiatry

Aberrant Developmental Patterns of Gamma-Band Response and Long-Range Communication Disruption in Youths With 22q11.2 Deletion Syndrome

Valentina Mancini et al.

Summary: This study investigates the abnormalities in brain oscillations in 22q11.2 deletion carriers and reveals more severe abnormalities associated with psychotic symptoms. The study also demonstrates the lack of age-related changes in deletion carriers, indicating potential developmental impairments.

AMERICAN JOURNAL OF PSYCHIATRY (2022)

Article Neurosciences

Oscillatory Neural Signatures of Visual Perception Across Developmental Stages in Individuals With 22q11.2 Deletion Syndrome

Valentina Mancini et al.

Summary: Individuals with 22q11.2 deletion syndrome exhibit decreased theta and gamma band responses to visual stimuli, while maintaining alpha/beta desynchronization. The lack of age-related changes in neural oscillations suggests developmental impairments in circuit mechanisms. The dissociation between the maturation of theta/gamma and alpha/beta band responses may indicate a selective impairment in cortical layers, leading to compensatory top-down connectivity.

BIOLOGICAL PSYCHIATRY (2022)

Article Clinical Neurology

Selective Effects of Methylphenidate on Attention and Inhibition in 22q11.2 Deletion Syndrome: Results From a Clinical Trial

Johanna Maeder et al.

Summary: This study extends the current knowledge on the effects of MPH in patients with 22q11DS. Treatment was found to be effective for core ADHD symptoms and cognitive measures of attention and inhibition. However, no significant improvement was found for other executive functions, learning, or memory. The side effects were frequent but mild in intensity.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2022)

Review Neurosciences

Adolescent Neurodevelopment and Vulnerability to Psychosis

Pooja K. Patel et al.

Summary: Adolescence is a period characterized by significant changes in various domains, some of which may increase the risk of psychosis onset while others may reduce it. Researching the unique aspects of adolescence that serve as risk factors for schizophrenia spectrum disorders is crucial for understanding vulnerability to psychosis and potential interventions.

BIOLOGICAL PSYCHIATRY (2021)

Article Psychiatry

Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia

Yash B. Joshi et al.

Summary: The study demonstrates that the anticholinergic medication burden in schizophrenia is substantial, common, and associated with cognitive impairments across all cognitive domains. This cognitive impairment is negatively correlated with medication burden, and remains significant even after controlling for other variables.

AMERICAN JOURNAL OF PSYCHIATRY (2021)

Article Biochemistry & Molecular Biology

Altered cortical thickness development in 22q11.2 deletion syndrome and association with psychotic symptoms

Joelle Bagautdinova et al.

Summary: Schizophrenia is associated with reduced cortical thickness, with the 22q11.2 deletion syndrome (22q11DS) providing insights into brain maturation in high-risk individuals. The study found that individuals with 22q11DS showed increased cortical thickness from childhood and accelerated thinning in frontotemporal regions during adolescence, with thinning in the superior temporal gyrus potentially serving as an early biomarker for psychotic symptoms.

MOLECULAR PSYCHIATRY (2021)

Article Psychiatry

Long-term effects of early treatment with SSRIs on cognition and brain development in individuals with 22q11.2 deletion syndrome

Valentina Mancini et al.

Summary: Cognitive deficits in individuals at risk of psychosis may be related to the occurrence of psychotic symptoms, and early long-term treatment with SSRIs may help attenuate cognitive decline associated with mental illness and promote brain development.

TRANSLATIONAL PSYCHIATRY (2021)

Review Genetics & Heredity

22q11.2 deletion syndrome and congenital heart disease

Elizabeth Goldmuntz

AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2020)

Article Neurosciences

Abnormal Development and Dysconnectivity of Distinct Thalamic Nuclei in Patients With 22q11.2 Deletion Syndrome Experiencing Auditory Hallucinations

Valentina Mancini et al.

BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING (2020)

Review Clinical Neurology

Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment

Christoph U. Correll et al.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2020)

Review Neurosciences

Alterations in cortical interneurons and cognitive function in schizophrenia

Samuel J. Dienel et al.

NEUROBIOLOGY OF DISEASE (2019)

Review Genetics & Heredity

Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review

Janna de Boer et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2019)

Article Biochemistry & Molecular Biology

Long-Lasting Rescue of Network and Cognitive Dysfunction in a Genetic Schizophrenia Model

Arghya Mukherjee et al.

Article Pediatrics

The Effectiveness and Safety of Antipsychotic and Antidepressant Medications in Individuals with 22q11.2 Deletion Syndrome

Netta Dori et al.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2017)

Article Genetics & Heredity

The Clinical Presentation of Attention Deficit-Hyperactivity Disorder (ADHD) in Children With 22q11.2 Deletion Syndrome

Maria Niarchou et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2015)

Review Psychology, Developmental

Corrected QT Changes During Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-Analysis of Clinical Trials

Karsten Giessing Jensen et al.

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2015)

Article Medicine, General & Internal

22q11.2 deletion syndrome

Donna M. McDonald-McGinn et al.

NATURE REVIEWS DISEASE PRIMERS (2015)

Article Psychology, Developmental

Subthreshold Psychotic Symptoms in 22q11.2 Deletion Syndrome

Sunny X. Tang et al.

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2014)

Review Biochemistry & Molecular Biology

Neurodevelopmental model of schizophrenia: update 2012

J. L. Rapoport et al.

MOLECULAR PSYCHIATRY (2012)

Article Multidisciplinary Sciences

Rethinking schizophrenia

Thomas R. Insel

NATURE (2010)

Article Neurosciences

Neuronal Gamma-Band Synchronization as a Fundamental Process in Cortical Computation

Pascal Fries

Annual Review of Neuroscience (2009)

Review Psychology, Clinical

Working memory in schizophrenia: a meta-analysis

N. F. Forbes et al.

PSYCHOLOGICAL MEDICINE (2009)

Article Genetics & Heredity

Schizophrenic-like neurocognitive deficits in children and adolescents with 22q11 deletion syndrome

Kathryn Eve Lewandowski et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)

Article Psychiatry

The effects of clozapine and risperidone on spatial working memory in schizophrenia

SR McGurk et al.

AMERICAN JOURNAL OF PSYCHIATRY (2005)

Review Clinical Neurology

Effect of switching to atypical antipsychotics on memory in patients with chronic schizophrenia

K Mori et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)